Key facts
- This page summarizes Albert Bourla's Form 4 filing for PFIZER INC (PFE).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 02 Dec 2024, 16:18.
Albert Bourla - 29 Nov 2024 Form 4 Insider Report for PFIZER INC (PFE)
- Signature
- Susan E. Grant, by power of atty., for Albert Bourla
- Issuer symbol
- PFE
- Transactions as of
- 29 Nov 2024
- Net transactions value
- +$524
- Form type
- 4
- Filing time
- 02 Dec 2024, 16:18:17 UTC
- Previous filing
- 18 Nov 2024
- Next filing
- 17 Dec 2024
- SEC
- View on sec.gov
Key filing fact
Albert Bourla filed Form 4 for PFIZER INC (PFE) on 02 Dec 2024.
Change
- Previous filing in this sequence was filed on 18 Nov 2024.
- Current net transaction value: +$524.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
PFE
transaction
Derivative
Phantom Stock Units SSP
Award
- Transaction value
- $524
- Shares
- +20
- Change %
- +0%
- Price
- $26.21
- Shares after
- 690,388
- Date
- 29 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20
- Exercise price
- Footnotes
- F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Each unit represents one phantom share of common stock. |
| F2 | These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |